Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.

G lucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide -- better known as Ozempic -- have ...

Kennedy Jr., who was tapped to lead the Department of Health and Human Services for the Trump administration, recently ...

Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.

With semaglutide shortages in the rearview, Novo Nordisk is doubling down on marketing efforts for its GLP-1 drugs.

Weight loss drugs like Ozempic deliver more health benefits than expected.

Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat ...

These GLP-1 agonists include semaglutide, liraglutide, and dulaglutide, now marketed as Ozempic, Wegovy ... were 49% less ...

Glucagon-like peptide-1 (GLP-1) drugs mimic the GLP-1 hormone, which helps control insulin and blood sugar levels, decreases ...

Novo Nordisk launched "My Ozempic® Era" today, a national campaign which spotlights the longstanding Ozempic® patient ...

Acclaimed vocalist Michael Trotter Jr. of the husband-and-wife duo The War and Treaty, reveals his diabetes diagnosis in ...